BIA
TCON

BHK Investment Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

BHK Investment Advisors’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed -$4K – 83
2019
Q3 		$4K Hold
50
– – ﹤0.01% 80
2019
Q2 		$7K Hold
50
– – ﹤0.01% 88
2019
Q1 		$14K Hold
50
– – 0.01% 89
2018
Q4 		$6K Buy
+50
New +$13.6K ﹤0.01% 70

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

BHK Investment Advisors's TCON Position: Q4 2019 in Review

BHK Investment Advisors sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2019, closing a stake of 50 shares — an estimated $4K sold.

BHK Investment Advisors first reported a position in TCON in Q4 2018 and held it in 4 quarters. The position peaked at $14K in Q1 2019. 15 funds tracked by Wall St. Rank hold TCON as of Q4 2019.

  • BHK Investment Advisors reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • BHK Investment Advisors sold 50 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $4K.
  • BHK Investment Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • BHK Investment Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $14K in Q1 2019.
  • 15 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on BHK Investment Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.